Trials / Completed
CompletedNCT06354270
A Clinical Study to Evaluate the Anti-Sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers
An 8-Week, Randomized, Controlled, Examiner-Blind, Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste for the Relief of Dentin Hypersensitivity in a Population of Dentin Hypersensitivity Sufferers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- HALEON · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to confirm the clinical Dentin Hypersensitivity (DH) efficacy of a 0.454 percent (%) Stannous Fluoride (SnF2) toothpaste.
Detailed description
This will be a single center, 8-week, randomized, controlled, examiner-blind, 2-treatment arm, parallel design, stratified (by maximum baseline Schiff sensitivity score of the two selected 'test teeth') clinical study to evaluate the anti-sensitivity efficacy of a 0.454% SnF2 toothpaste in healthy participants with DH. The clinical efficacy of the 0.454% SnF2 toothpaste (test toothpaste) will be compared with that of a reference toothpaste, a commercially available, regular fluoride toothpaste with no known anti-sensitivity properties (negative control). Sufficient participants will be screened to randomize approximately 110 participants to investigational product (approximately 55 per treatment group) and to ensure approximately 100 evaluable participants complete the entire study (approximately 50 per treatment group).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Stannous fluoride toothpaste | Toothpaste containing 0.454 % weight/weight (w/w) SnF2. |
| DRUG | Regular fluoride toothpaste (Crest Cavity Protection) | Regular fluoride toothpaste containing 1100 parts per million (ppm) fluoride. |
Timeline
- Start date
- 2024-04-11
- Primary completion
- 2024-06-23
- Completion
- 2024-06-23
- First posted
- 2024-04-09
- Last updated
- 2025-06-25
- Results posted
- 2025-06-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06354270. Inclusion in this directory is not an endorsement.